Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


MHLW approval of Lumicef for palmoplantar pustulosis in Japan – Kyowa Kirin

Written by | 30 Aug 2023

Kyowa Kirin Co., Ltd. announces that the company has received approval from the Ministry of Health, Labour and Welfare (“MHLW”) for partial change of approved indication of Lumicef… read more.

Arcutis and Huadong announce strategic collaboration and licensing agreement for topical roflumilast in Greater China and Southeast Asia

Written by | 20 Aug 2023

Arcutis Biotherapeutics, Inc. and Hangzhou Zhongmei Huadong Pharmaceutical Co, a wholly owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963), announced that the companies have entered into a strategic… read more.

Bristol Myers Squibb launches Clear Understanding Campaign to reveal the plain truth about living with moderate to severe plaque psoriasis

Written by | 16 Aug 2023

Bristol Myers Squibb has launched Clear Understanding, a campaign featuring patients living with moderate to severe plaque psoriasis who are sharing what it’s really like for them to… read more.

Holidaymakers be warned: Short, intense sun-seeking trips can disrupt skin’s microbiome

Written by | 10 Aug 2023

Skin, the largest organ of the human body, is home to a vast array of bacteria, fungi, and viruses – microorganisms that compose the skin microbiota. Among other… read more.

Large study shows link between Vitamin D and psoriasis severity

Written by | 31 Jul 2023

More than eight million people in the U.S. experience psoriasis, a condition in which skin cells build up and form itchy dry patches. A person’s vitamin D levels… read more.

Phase III TRuE-AD3 study of Opzelura meets primary endpoint in atopic dermatitis – Incyte

Written by | 20 Jul 2023

Incyte announced positive topline results from its randomized, vehicle-controlled, pivotal Phase III TRuE-AD3 study evaluating the safety and efficacy of Opzelura (ruxolitinib cream) in children (age at least… read more.

Curettage and cryosurgery – effective for the most common skin cancer

Written by | 16 Jul 2023

The combination of curettage and cryosurgery is a safe and effective treatment method for the most common form of skin cancer, basal cell carcinoma. A study from the… read more.

European Commission approval for Cosentyx as first and only IL-17A inhibitor for hidradenitis suppurativa – Novartis

Written by | 14 Jun 2023

Novartis announced that the European Commission (EC) has approved Cosentyx (secukinumab) for use in adults with active moderate to severe hidradenitis suppurativa (HS) and an inadequate response to… read more.

Study helps explain what drives psoriasis severity and offers clues as to how disease may spread to other body parts

Written by | 7 Jun 2023

Beneath and beyond the reddish, flaky lesions that form in the skin of those with psoriasis, mild and severe forms of the disease can be told apart by… read more.

New type of drug candidate effectively accelerates wound healing in clinical study

Written by | 6 Jun 2023

Complicated, hard-to-heal wounds are a growing medical problem and there are currently only two drugs approved with proven efficacy. In a new study on humans, researchers at Uppsala… read more.

Non-antibiotic treatment for women with persistent acne shown to be effective

Written by | 21 May 2023

A team of researchers led by the University of Southampton has shown that a cheap and readily available drug, used to treat high blood pressure, could help the… read more.

Study shows promising results for immunotherapy targeting skin cancer

Written by | 28 Apr 2023

A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer. The study, published today in Nature Communications by researchers from King’s College London… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.